Le Lézard
Classified in: Health
Subjects: MAV, CFG

Media Advisory - Prime Minister's itinerary for Thursday, March 7, 2024


OTTAWA, ON, March 6, 2024 /CNW/ -

Note: All times local

Greater Toronto Area, Ontario


The Prime Minister will meet with nurses and physicians.


Note for media:

  • Pooled photo opportunity

The Prime Minister will make a pharmacare announcement. The Deputy Prime Minister
and Minister of Finance, Chrystia Freeland, and the Minister for Women and Gender
Equality and Youth, Marci Ien, will also be in attendance. A media availability will follow.


Notes for media: 

  • Open coverage
  • Media are asked to arrive no later than 10:30 a.m.
  • Media interested in participating can contact [email protected] for details.

The Prime Minister will meet with health care professionals and non-profit diabetes
advocates.


Note for media:

  • Pooled photo opportunity

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 00:20
PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...

at 00:00
INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...

at 00:00
SPECTRUM DYNAMICS MEDICAL AND HERMES MEDICAL SOLUTIONS ENTER INTO PARTNERSHIP TO OFFER INTEGRATED SOLUTION OF THE HERMIA SOFTWARE WITH THE VERITON-CT SCANNER
Spectrum Dynamic's customers will...

28 avr 2024
AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...

28 avr 2024
Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRAtm
Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans covering more than 100 million people. The agreement, effective...

28 avr 2024
Marc Dubrick and Lisa Becharas Win St. Anthony's Triathlon
Marc Dubrick and Lisa Becharas are bringing victories home to Boulder, Colorado, after winning their first St. Anthony's Triathlon along St. Petersburg's scenic downtown waterfront. The winners, who are teammates on The Real Triathlon Squad, raced a...

More news about Health...


News published on and distributed by: